Perioperative use of selective serotonin reuptake inhibitors and risks for adverse outcomes of surgery.
about
Depression and postoperative complications: an overviewLeveraging a critical care database: selective serotonin reuptake inhibitor use prior to ICU admission is associated with increased hospital mortality.SSRIs increase risk of blood transfusion in patients admitted for hip surgery.Course of depressive symptoms and treatment in the longitudinal assessment of bariatric surgery (LABS-2) study.Arterial pressure above the upper cerebral autoregulation limit during cardiopulmonary bypass is associated with postoperative deliriumDepression, anxiety and major adverse cardiovascular and cerebrovascular events in patients following coronary artery bypass graft surgery: a five year longitudinal cohort studyRoyal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders.Serotonergic antidepressants and increased bleeding risk in patients undergoing breast biopsy.Serotonergic antidepressants and perioperative bleeding risk: a systematic review.Vintage treatments for PTSD: a reconsideration of tricyclic drugs.Antidepressant Drugs for Postsurgical Pain: Current Status and Future Directions.Selective Serotonin Reuptake Inhibitors and Operative Bleeding Risk: A Review of the Literature.Psychopharmacologic treatment and blood transfusion in fast-track total hip and knee arthroplasty.Selective serotonin reuptake inhibitors and perioperative bleeding in endoscopic dacryocystorhinostomy.Evaluating the cosmetic patient on antidepressants.Selective serotonin reuptake inhibitor use and mortality, postoperative complications, and quality of care in hip fracture patients: a Danish nationwide cohort study
P2860
Q26772908-D11FF762-1DC6-4900-BF6F-057EF6124BCEQ30406020-8BF62B45-FF0A-4415-80E4-FE697BEA14F7Q33644329-5DAA9602-ADFE-4FE1-A386-4031551E1E9EQ33969243-4EA1A3F8-9302-480D-BB06-AD6081CA7B88Q34532619-BE0A14D0-991B-420E-9F22-83BFD699F711Q35652164-ABA9CD08-5E2D-476B-878F-A0D7A441E3F8Q35862776-C94D12A7-5711-4086-9A74-F26B3E8A1707Q36489417-261E3820-3BF3-4083-B2D2-4D318FFF94DEQ38203347-317A2C75-4CDA-4973-BA27-CA18A17BD85FQ38317410-68C002E3-52AA-49E2-9AD8-A8197AFDDAC8Q38687437-3C30383F-7DEA-4998-B349-BF0B366F9A03Q38967657-50F2CE89-D4E5-4266-97FE-7627789FD59EQ38987620-10D81BD5-185C-43F4-88A6-4403338F91C2Q42941185-1202267A-48B4-4099-8ADB-E3E465752DDEQ50661519-81B2BF79-3F3D-49F5-BEDC-DDE694A8896FQ58700924-328E9430-ED55-4311-B1E1-CE2494AD1465
P2860
Perioperative use of selective serotonin reuptake inhibitors and risks for adverse outcomes of surgery.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Perioperative use of selective ...... r adverse outcomes of surgery.
@en
Perioperative use of selective ...... r adverse outcomes of surgery.
@nl
type
label
Perioperative use of selective ...... r adverse outcomes of surgery.
@en
Perioperative use of selective ...... r adverse outcomes of surgery.
@nl
prefLabel
Perioperative use of selective ...... r adverse outcomes of surgery.
@en
Perioperative use of selective ...... r adverse outcomes of surgery.
@nl
P2093
P2860
P1476
Perioperative use of selective ...... r adverse outcomes of surgery.
@en
P2093
Andrew D Auerbach
Eric Vittinghoff
John Q Young
Judith Maselli
Penelope S Pekow
Peter K Lindenauer
P2860
P304
P356
10.1001/JAMAINTERNMED.2013.714
P577
2013-06-01T00:00:00Z